Recordati Industria Chimica e Farmaceutica S.p.A. (FRA:RER1)
Germany · Delayed Price · Currency is EUR 50.35
+0.30 (0.60%)
At close: Nov 27, 2025
FRA:RER1 Revenue
Recordati Industria Chimica e Farmaceutica had revenue of 632.32M EUR in the quarter ending September 30, 2025, with 13.44% growth. This brings the company's revenue in the last twelve months to 2.55B, up 12.58% year-over-year. In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B with 12.45% growth.
Revenue (ttm)
2.55B
Revenue Growth
+12.58%
P/S Ratio
4.03
Revenue / Employee
562.82K
Employees
4,583
Market Cap
10.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.34B | 259.23M | 12.45% |
| Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
| Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
| Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
| Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
Recordati Industria Chimica e Farmaceutica News
- 19 days ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Amarin outlines accelerated path to positive free cash flow in 2026 supported by Recordati partnership and $70M OpEx savings - Seeking Alpha
- 4 months ago - Italy's Recordati CEO sees rare disease drugs exempt from U.S. tariffs - Reuters
- 4 months ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
- 7 months ago - RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2% - GlobeNewsWire
- 1 year ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q2 2023 Earnings Call Transcript - Seeking Alpha